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The B cell activating factor belonging to the tumor necrosis factor family (BAFF) is required 
for B cell survival and maturation. The mechanisms by which BAFF mediates B cell survival 
are less understood. We found that BAFF and a proliferation-inducing ligand (APRIL), which 
are related, block B cell antigen receptor (BCR)–induced apoptosis upstream of mitochondrial 
damage, which is consistent with a role for Bcl-2 family proteins. BCR ligation strongly 
increased expression of the proapoptotic Bcl-2 homology 3–only Bcl-2 protein Bim in both 
WEHI-231 and splenic B cells, and increases in Bim were reversed by BAFF or APRIL. Small 
interfering RNA vector–mediated suppression of Bim blocked BCR-induced apoptosis. BAFF 
also induced Bim phosphorylation and inhibited BCR-induced association of Bim with Bcl-2. 
BAFF induced delayed but sustained stimulation of extracellular signal–regulated kinase 
(ERK) and its activators, mitogen-activated protein kinase/ERK activating kinase (MEK) and 
c-Raf, and MEK inhibitors promoted accumulation and dephosphorylation of Bim. These 
results suggest that BAFF inhibits BCR-induced death by down-regulating Bim via sustained 
ERK activation, demonstrating that BAFF directly regulates Bim function. Although 
transitional immature type 1 (T1) B cell numbers are normal in Bim
 
 
 
/
 
 
 
 mice, T2 and 
follicular mature B cells are elevated and marginal zone B cells are reduced. Our results 
suggest that mature B cell homeostasis is maintained by BAFF-mediated regulation of Bim.
 
Apoptosis plays an essential role in the develop-
ment and maintenance of cellular homeostasis of
the mammalian immune system. The survival
and death of hematopoietic cells, including B
lymphocytes, is finely tuned; excessive apoptosis
may lead to immunodeficiencies, whereas too
little cell death may cause autoimmunity and
cancers (1, 2). During B lymphocyte develop-
ment, progression from the splenic immature
transitional immature type 1 (T1) B cell to the
T2 stage is critical for establishing long-lived
mature B cells (3). Thus, at the bone marrow
immature stage and the splenic T1 stage, B
cells expressing either nonfunctional or autoreac-
tive B cell antigen receptors (BCRs) are deleted
by neglect and negative selection, respectively
(4). Components of both the BCR signaling
pathway (e.g., Ig
 
 
 
 and Syk) and the B cell acti-
vating  factor belonging to the TNF family
(BAFF; BLyS/TALL-1/THANK/zTNF4) are
required for T1 to T2 B cell progression (5–8).
BAFF is both a B cell survival and matu-
ration factor (7–9). It binds three TNF family
receptors: BAFF-R (BR3), B cell maturation
antigen (BCMA), and transmembrane activa-
tor and cyclophilin ligand interactor (TACI)
(7, 8). A second, highly related homologue, a
proliferation-inducing ligand (APRIL), also
binds TACI and BCMA but not BAFF-R (7,
8). The mechanisms by which BAFF regulates
B cell survival are not well-defined. BAFF
blocks nuclear translocation of protein kinase
C
 
 
 
 (PKC
 
 
 
), and BAFF-mediated B cell sur-
vival is impaired in PKC
 
 
 
 KO mice (10). Like
other antiapoptotic TNF homologues such as
CD40L and receptor activator of NF-
 
 
 
B
ligand, BAFF promotes NF-
 
 
 
B activation (11–
14). BAFF activates NF-
 
 
 
B via two distinct
mechanisms: (a) I
 
 
 
B degradation and subsequent
nuclear translocation of active NF-
 
 
 
B dimers
and (b) NF-
 
 
 
B–inducing kinase–mediated
processing of p100 precursors to active p52
subunits. Mice deficient in both NF-
 
 
 
B1 and
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NF-
 
 
 
B2, similar to BAFF KO animals (7, 8), have a defect
in progression of B cells from the T1 to T2 B cell stage.
Consistent with a role for NF-
 
 
 
B signaling in BAFF-medi-
ated B cell survival, BAFF enhances mRNA levels of three
NF-
 
 
 
B–regulated antiapoptotic Bcl-2 family members, Bcl-2,
Bcl-x
 
L
 
, and A1/Bfl-1 (11, 12, 14, 15).
The Bcl-2 homology 3 (BH3)–only subgroup of the Bcl-2
family includes Bid, Bad, Bik, Bim, Bmf, Hrk/DP5, Noxa,
and Puma. These proteins share only the BH3 domain with
other Bcl-2 family members and are proapoptotic (2, 16,
17). BH3-only proteins serve as sentinels for specific apop-
totic stimuli. They initiate programmed cell death via inter-
action with and blockade of prosurvival Bcl-2 family mem-
bers (18). In particular, the BH3-only protein Bim is critical
for apoptosis of hematopoietic cells, including B and T
lymphocytes, macrophages, and granulocytes (19). Indeed,
experiments using Bim KO mice indicate that Bim is re-
quired for negative selection of T lymphocytes and is up-
regulated by TCR ligation (20). Similarly, BCR-induced
apoptosis is strongly reduced in immature and mature B cells
from Bim KO mice, and the deletion of autoreactive B cells
is also inhibited (21). Furthermore, autoantigen-stimulated B
cells from Ig/HEL double transgenic mice express elevated
levels of Bim mRNA and protein (22).
The proapoptotic activity of Bim can be regulated at
both the transcriptional and posttranslational levels. In re-
sponse to growth factor withdrawal and concomitant block-
ade of the phosphatidylinositol 3-kinase–Akt pathway, Bim
mRNA levels are up-regulated by activation of the fork-
head-like transcription factor FoxO3A/FKHRL-1 (23). At
least two mechanisms exist for the posttranslational control
of Bim: phosphorylation and ubiquitination. Phosphoryla-
tion of Bim is mediated by either extracellular signal–regu-
lated kinase (ERK) or c-Jun NH
 
2
 
-terminal protein kinase
promoting changes in its proapoptotic activity (24–30).
ERK-induced phosphorylation of Bim promotes its ubiq-
uitination and subsequent degradation via the proteasome
(26, 27, 30).
The B cell phenotype of BAFF transgenic mice is re-
markably similar to that observed in mice lacking Bim. Both
lines of mice have enlarged spleens, with elevated numbers of
mature B cells and autoantibody-secreting plasma cells. Older
mice also develop systemic lupus erythematosus–like autoim-
mune kidney disease (19, 31). Based on these similarities, we
hypothesized that BAFF may promote B cell survival by
down-regulating Bim. Using the immature WEHI-231 B
cell line, which is a model for the deletion of autoreactive B
cells (32, 33), and splenic B cells, we found that BCR signal-
ing up-regulates Bim, and that BAFF blocks BCR-induced
increases in Bim. BAFF signaling induced phosphorylation of
Bim via a mitogen-activated protein kinase (MAPK)/ERK
activating kinase (MEK)–dependent pathway and also pro-
moted sustained ERK activation. Our results suggest that
BAFF inhibits BCR-induced cell death by down-regulating
Bim and that BAFF promotes Bim down-regulation via sus-
tained activation of ERK. Based on the phenotype of Bim
 
 
 
/
 
 
 
mice, we propose that BAFF regulates Bim at the transitional
B cell stage to control B cell homeostasis.
Figure 1. BAFF and APRIL block BCR-induced apoptosis in WEHI-231 
B Cells. (A) WEHI-231 cells were treated for 48 h with anti-IgM in the 
presence or absence of BAFF or APRIL, and apoptotic cells were quantified 
by FACS using TdT-mediated dUTP nick-end labeling. Results show the 
means   SD from three independent experiments. (B) Binding of BAFF to 
Daudi (left) and WEHI-231 (right) B cell lines was detected by FACS using 
biotinylated BAFF and streptavidin–PE. Biotinylated BAFF   streptavidin–PE 
(shaded) and streptavidin–PE only (bold line) traces are shown. Results 
shown are from one of three experiments. (C) Daudi cells were treated for 
48 h with anti-IgM in the presence (open bar) or absence (shaded bar) of 
BAFF or etoposide (as a positive control), and cell death was quantified by 
FACS using Mitotracker Red CMXRos. Results shown are from one of two 
experiments. (D) BAFF-R, TACI, BCMA, and  -actin (as a loading control) 
were amplified by RT-PCR using gene-specific primers from fourfold serial 
dilutions of WEHI-231, A20, and splenic B cell cDNA (Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20051283/DC1). PCR products 
were resolved on NuSieve 3:1 agarose. 
JEM VOL. 202, November 21, 2005
 
1365
 
ARTICLE
 
RESULTS
BAFF and APRIL inhibit BCR-induced cell death 
in WEHI-231 B cells
 
WEHI-231 B cells, like T1 B cells, undergo programmed cell
death in response to BCR engagement (33–35). We initially
tested the effect of BAFF and APRIL on BCR-induced cell
death in WEHI-231 B cells. BCR engagement with goat anti–
mouse IgM F(ab
 
 
 
)
 
2
 
 fragments induced apoptosis, and treatment
with either BAFF or APRIL inhibited BCR-induced cell
death (Fig. 1 A). Thus, WEHI-231 B cells express functional
receptors for BAFF and APRIL, and BAFF and APRIL block
BCR-induced cell death. Using a biotinylated derivative of
BAFF, we found that WEHI-231 B cells have high relative
levels of BAFF binding (Fig. 1 B). In contrast, the Burkitt’s
lymphoma line Daudi did not bind BAFF, and, as expected,
BAFF did not block BCR-induced cell death in Daudi B cells
(Fig. 1 C). RT-PCR analysis revealed that WEHI-231 B cells
expressed similar levels of BAFF-R and moderately higher
TACI levels compared with A20 and splenic B cells, but unlike
splenic B cells, which expressed BCMA, neither WEHI-231
nor A20 cells expressed BCMA mRNA (Fig. 1 D). As APRIL
binds only to TACI and BCMA (7, 8), these results suggest
that APRIL-induced blockade of BCR-mediated cell death in
WEHI-231 B cells is most likely mediated through TACI.
 
BAFF and APRIL inhibit BCR-induced apoptosis upstream of 
mitochondrial inner membrane depolarization 
and caspase-9 cleavage
 
To define how BAFF and APRIL block BCR-induced cell
death, we next examined the effect of BAFF and APRIL on
various components of the BCR-induced cell death path-
way, including the effector caspase substrate poly(ADP-ribose)
polymerase (PARP), caspase-3, and caspase-9 (36, 37). Anti-
IgM antibodies induced cleavage of full-length PARP to its
apoptotic fragment within 24 h, which was further increased
at 48 h (Fig. 2 A). BAFF or APRIL strongly reduced anti-
IgM–mediated PARP cleavage (Fig. 2 A). BCR cross-linking
also resulted in increases in cleaved caspase-3 and processing
of pro–caspase-9 (Fig. 2 A), which is required for activation
of caspase-3–like effector caspases in WEHI-231 B cells (38).
BAFF or APRIL blocked BCR-induced accumulation of
both cleaved caspase-3 and cleavage of pro–caspase-9 (p47) to
its large active 35-kD fragment (p35; Fig. 2 A). Thus, BAFF
and APRIL block BCR-induced cell death upstream of
BCR-induced pro–caspase-9 and -3 processing.
Because mitochondrial perturbations including the re-
lease of cytochrome C and inner membrane depolarization
are upstream of caspase-9 and -3 activation (39) and are re-
quired for pro–caspase-9 processing during BCR-induced
apoptosis (38), we tested whether BAFF could block BCR-
induced depolarization of the mitochondrial inner mem-
brane. A decrease in mitochondrial membrane potential
(
 
  
 
m) was detected 24 h after BCR ligation, decreasing fur-
ther by 48 h (Fig. 2 B). This loss of mitochondrial inner
membrane potential after BCR ligation was abrogated by
BAFF in a dose-dependent manner (Fig. 2 C). Thus, BAFF
and APRIL block the BCR-induced cell death pathway up-
stream of mitochondrial damage.
 
BAFF and APRIL down-regulate BCR-induced 
expression of Bim
 
The fact that BAFF blocks BCR-induced cell death up-
stream of mitochondrial damage suggested that BAFF may
regulate apoptosis by controlling the activity of one or more
Bcl-2 family proteins. The phenotypes of B cells from BAFF
transgenic and Bim KO mice are strikingly similar, with ele-
vated numbers of mature B cells and plasma cells (19, 31).
Hence, we tested whether BAFF and BCR cross-linking re-
ciprocally regulated Bim levels in WEHI-231 B cells. Similar
to other cells, including primary mouse B cells (21, 22),
WEHI-231 B cells expressed much higher levels of BimEL
than BimL or BimS (Fig. 3 A). BCR cross-linking induced a
Figure 2. BAFF and APRIL block BCR-induced cell death upstream 
of caspase-3 and -9 activation and mitochondrial inner membrane 
depolarization. (A) WEHI-231 cells were treated for the indicated times 
with anti-IgM antibodies in the presence or absence of BAFF or APRIL. 
Immunoblots were probed with anti-PARP, anti–cleaved caspase-3, or 
anti–caspase-9. n.s., nonspecific. (B) WEHI-231 cells were treated for 24 or 
48 h with either medium, anti-IgM, or etoposide (as a positive control). 
(top right) Percentages of Mitotracker Red CMXRos–low cells are shown. 
(C) WEHI-231 cells were stimulated for 48 h with the indicated concentra-
tions of BAFF in the presence ( ) or absence ( ) of anti-IgM.   m was 
determined by FACS using Mitotracker Red CMXRos. Results shown are 
the means   SD from three experiments. 
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dramatic increase in the levels of BimEL detectable at 24 h
and maximal at 48 h (Fig. 3 B). BAFF or APRIL markedly
reduced BCR-mediated increases in BimEL protein levels
(Fig. 3 B), and this correlated with blockade of BCR-
induced cell death (Fig. 1 A). We then tested whether BAFF
also down-regulated Bim expression in mouse splenic B
cells. BCR ligation increased the levels of Bim protein (both
BimL and BimEL isoforms) threefold in splenic B cells (Fig.
3 C). Similar to our results in WEHI-231 B cells, BAFF
markedly reduced BCR-induced Bim expression in splenic
B cells to levels seen in unstimulated B cells (Fig. 3 C).
Because BAFF and APRIL blocked BCR-induced ex-
pression of Bim, we tested whether engagement of CD40,
another TNF receptor whose ligation blocks BCR-
induced cell death (32), also reduced BCR-induced Bim
expression. CD40 ligation also blocked BCR-mediated
increases in BimEL protein (Fig. 3 D). In contrast, neither
BAFF nor CD40 ligation regulated expression of Bmf, an-
other BH3-only Bcl-2 family member. We also examined
whether BAFF regulated expression of two key prosur-
vival Bcl-2 family members, Bcl-x
 
L
 
 or Bcl-2, in these cells.
Although CD40 ligation increased the levels of Bcl-x
 
L
Figure 3. BAFF- and APRIL-induced down-regulation of Bim 
correlates with a blockade of BCR-induced apoptosis. (A) NP-40 lysates 
from WEHI-231 cells were immunoprecipitated with anti-Bim mAb or IgG2a 
isotype control. Immune complexes were probed with anti-Bim serum. 
Positions of Bim isoforms including multiple BimEL species are shown by 
arrows. (B) WEHI-231 cells were incubated for 0–48 h with anti-IgM, BAFF, 
or APRIL (as in Fig. 2 A). Western blots were probed with anti-Bim or anti-
APRIL serum (loading control). (C) Purified mouse splenic B cells were incu-
bated with anti-IgM and/or BAFF for 24 h. Immunoblots were probed with 
anti-Bim or anti-actin serum (loading control). The ratio of BimEL to actin 
was assessed by scanning densitometry. Dividing lines separate images 
from different parts of the same gel. (D) WEHI-231 cells were treated for 
the indicated times with anti-IgM, BAFF, or anti-CD40. Immunoblots were 
probed with anti-Bim, anti–Bcl-xL, anti-Bmf, or anti–NF- B2 serum. Non-
specific (n.s.) proteins serve as loading controls. (E and F) WEHI-231 cells 
were incubated with anti-IgM antibodies and/or BAFF as indicated. Bim (E) 
or Bcl-2 (F) were immunoprecipitated from NP-40 lysates, which were 
probed with anti–Bcl-2 or anti-Bim, stripped, and reprobed with anti-Bim 
or anti–Bcl-2, respectively. Nonspecific (n.s.) bands are indicated. The ratio 
of Bcl-2 to Bim was quantified by scanning densitometry. 
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protein, BAFF did not up-regulate Bcl-x
 
L
 
 or Bcl-2 expres-
sion (Fig. 3 D and see Fig. 5 C). However, BAFF did reg-
ulate the association of Bim with Bcl-2. In the absence of
BCR cross-linking, little Bim associated with Bcl-2 (Fig.
3, E and F). However, BCR cross-linking promoted a
strong association of Bcl-2 with Bim (Fig. 3, E and F). Im-
portantly, Bim-Bcl-2 interactions were considerably re-
duced in B cells treated with both anti-IgM and BAFF
(Fig. 3, E and F).
 
Down-regulation of Bim blocks BCR-induced cell death
 
To test whether down-regulating Bim expression inhibits
BCR-induced apoptosis in WEHI-231 B cells, endogenous
Bim levels were knocked down by stable overexpression of
Bim small interfering RNA (siRNA). BimEL levels were
strongly reduced in B cells overexpressing Bim488siRNA,
in contrast to B cells expressing a vector control or another
Bim siRNA, Bim13siRNA (Fig. 4 A). Importantly, BCR-
induced cell death was also decreased by 50–75% at a range
of doses of anti-IgM antibodies in the Bim488siRNA-
expressing B cells compared with control or Bim13siRNA-
expressing cells (Fig. 4 B). These results show that down-
regulating endogenous Bim levels strongly reduces
BCR-mediated apoptosis in WEHI-231 B cells, similar to
immature Bim KO splenic B cells (21). Together, our re-
sults suggest BAFF inhibits BCR-induced cell death by
down-regulating Bim.
 
BAFF promotes Bim phosphorylation via sustained activation 
of a MEK–ERK–dependent pathway
 
In addition to lowering BimEL levels, BAFF signaling gen-
erated BimEL species with reduced mobility on SDS-PAGE
(Fig. 3), suggesting that BimEL may be posttranslationally
modified in B cells. Indeed, BimEL can be posttranslation-
ally regulated via phosphorylation and/or ubiquitination in
other cells (24–30). Thus, we tested whether the slower mi-
grating forms of BimEL in WEHI-231 B cells treated with
BAFF were caused by phosphorylation of BimEL. We com-
pared the mobility of BimEL from BAFF-, anti-IgM–, and
anti-CD40–stimulated B cells in the presence or absence of
 
 
 
 protein phosphatase, which dephosphorylates serine, thre-
onine, and tyrosine residues (40). Treatment with 
 
 
 
 protein
phosphatase increased the mobility of BimEL in BAFF- and
anti-CD40–treated B cells (Fig. 5 A). In contrast, the mobil-
ity of BimEL from WEHI-231 B cells stimulated with anti-
IgM antibodies for 24 h was unaltered by 
 
 
 
 protein phos-
phatase (Fig. 5 A).
Previous studies have shown that prosurvival signals, in-
cluding the TNF family ligands receptor activator of NF-
 
 
 
B
ligand and nerve growth factor, induce phosphorylation of
BimEL via the MEK–ERK pathway (24, 30). To test
whether the MEK–ERK pathway was required for BAFF-
induced BimEL phosphorylation in B cells, WEHI-231 cells
were pretreated with U0126, a specific MEK inhibitor (41),
before stimulation by BAFF. U0126 increased both the mo-
bility and levels of BimEL from BAFF-treated B cells under
conditions in which ERK phosphorylation was markedly in-
hibited (Fig. 5 B), suggesting that BAFF-induced BimEL
phosphorylation via the MEK–ERK pathway down-regu-
lates BimEL expression. In contrast, a specific inhibitor of
p38 MAPK did not change the levels of BimEL from BAFF-
treated B cells even though a moderate increase in electro-
phoretic mobility was observed (Fig. 5 B).
Because these data suggested that BAFF regulates Bim
expression via a MEK-dependent pathway, we next tested
whether BCR and BAFF signaling differ in their regulation
of ERK activation using a phospho-specific ERK antibody
that detects only the phosphorylated, activated forms of
ERK. Although BCR cross-linking induced rapid activation
of ERK1 and -2 within 30 min, this ERK activation subse-
quently declined below basal levels within 16 h and re-
mained low (Fig. 5, C and D). In contrast, BAFF signaling
promoted a delayed but sustained phosphorylation of ERK1
and -2 that was only evident 4 h after BAFF stimulation
(Fig. 5, C and D). Importantly, in the presence of BAFF,
BCR-induced ERK1 and-2 activation was sustained for up
to 24 h (Fig. 5, C and D). BAFF may induce sustained ERK
activation by stimulating kinases upstream of ERK or, alter-
natively, by inhibiting protein phosphatases such as the dual-
specificity phosphatases (DUSPs) of MAPK phosphatase
(MKP), which dephosphorylate ERK (42). To investigate
these possibilities, we compared the effects of anti-IgM anti-
bodies and BAFF on the phosphorylation of two upstream
kinases: MEK and one of its activators, the MAPKKK mem-
Figure 4. Down-regulation of Bim inhibits BCR-induced apoptosis 
in WEHI-231 B cells. (A) Immunoblots were prepared as in Fig. 2 and 
probed with anti-Bim or anti-p38 MAPK (loading control). BimEL species 
migrating with different mobilities are indicated by arrows. (B) Stable 
WEHI-231 cell lines expressing either Bim-specific siRNAs or a control 
vector were treated for 48 h with the indicated doses of anti-IgM, and 
  m was determined by FACS using Mitotracker Red CMXRos. Results 
shown are the means   SD from three independent experiments. 
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ber c-Raf, whose phosphorylation on Ser 338 is required for
c-Raf activation in response to many stimuli (43). In addi-
tion, we monitored expression of two MKPs, MKP-2/
DUSP4 and MKP-3/DUSP6, which contain ERK-binding
FXFP motifs (42). Similar to our results with ERK, BCR
cross-linking induced strong but transient MEK and c-Raf
phosphorylation that declined below basal levels after 16–24
h, whereas BAFF induced delayed but sustained increases in
both MEK and c-Raf phosphorylation (Fig. 5, C and D).
BCR ligation also strongly up-regulated MKP-2 levels,
whereas MKP-3 levels were not substantially affected by
BCR cross-linking (Fig. 5 C and not depicted). Interest-
ingly, the initial BCR-mediated increases in MKP-2 protein
correlated with down-regulation of BCR-mediated ERK
activation, which was consistent with the idea that MKP-2
may be a critical negative feedback regulator of BCR-
induced ERK activation in B cells. In contrast, BAFF signal-
ing did not induce MKP-2 expression, which is consistent with
its ability to promote sustained ERK activation (Fig. 5 C).
Consistent with the distinct patterns of BCR- and BAFF-
induced ERK activation, BCR cross-linking also promoted
rapid but transient phosphorylation of Bim that was maximal
after 30 min, followed by its sustained accumulation at later
times (Fig. 5 C). Importantly, BAFF markedly blocked
BCR-induced Bim accumulation (Fig. 5 C). In summary,
these results suggest that sustained ERK activation by BAFF
correlates with its ability to promote down-regulation of
Bim and strongly suggest that BAFF promotes Bim down-
regulation via sustained activation of ERK. Furthermore, the
data suggest that BAFF induces ERK activation by activating
upstream kinases such as c-Raf rather than blockade of
BCR-mediated expression of MAPK phosphatases such as
MKP2/DUSP4.
 
Effect of individual BAFF receptors on BCR-induced 
cell death and Bim down-regulation
 
To examine the effects of individual BAFF receptors in reg-
ulating BCR-induced apoptosis and Bim expression in
WEHI-231 B cells, we developed a chimeric BAFF recep-
tor system. We created constructs where the extracellular
and transmembrane regions of each BAFF receptor were
substituted with the extracellular and transmembrane por-
tions of mouse CD8
 
 
 
 (Fig. 6 A). WEHI-231 B cells were
retrovirally transduced with CD8
 
 
 
-control, –BAFF-R,
-TACI, and -BCMA, and stable clonal cell lines were estab-
lished. Each chimeric BAFF receptor was expressed at simi-
Figure 5. BAFF induces Bim phosphorylation via sustained activation 
of the MEK–ERK pathway. (A) WEHI-231 cells were treated for 24 h 
with medium, anti-IgM, BAFF, or anti-CD40. Cell lysates were incubated 
with or without   protein phosphatase. Immunoblots were probed with 
anti-Bim serum. (B) WEHI-231 cells were pretreated for 2 h with DMSO 
vehicle, 5  M MEK inhibitor U0126 (U), or 5  M p38 MAPK inhibitor 
SB203580 (SB) before incubation with BAFF for 24 h. Blots were probed 
with anti-Bim, anti–phospho-ERK, or anti-actin (loading control). 
(C and D) WEHI-231 cells were treated for 0–24 h with anti-IgM in the 
presence or absence of BAFF. Immunoblots were probed with either anti–
phospho-ERK, anti–phospho-MEK, anti–phospho–c-Raf (Ser 338), anti-
MKP2, anti-Bim, or anti–Bcl-2 serum. In (D), immunoblots for ERK2 (top) 
or MEK1/2 (bottom) were quantified by scanning densitometry to measure 
the fold change in each phosphorylated protein. 
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lar levels on the clonal cell lines (Fig. 6 B). We incubated
each chimeric CD8
 
 
 
–BAFF receptor–expressing cell line
with anti-IgM, anti-CD8
 
 
 
, or a combination of both anti-
bodies for 48 h and quantified cell death. Cross-linking ei-
ther chimeric CD8
 
 
 
–BAFF-R, -TACI, or -BCMA but not
a control CD8
 
 
 
 receptor lacking a cytoplasmic domain sub-
stantially inhibited BCR-induced apoptosis (Fig. 6 C).
Thus, engagement of each BAFF receptor—BAFF-R,
TACI, or BCMA—blocks BCR-induced cell death in
WEHI-231 B cells.
As BAFF and APRIL strongly down-regulated BCR-
induced Bim expression (Fig. 3 B), we next examined the
effect of engaging each BAFF receptor on the blockade of
BCR-induced Bim expression by treating each WEHI-231–
CD8
 
 
 
–BAFF receptor B cell line with anti-IgM antibodies
in the presence or absence of anti-CD8
 
 
 
 for 48 h followed
by immunoblotting of Bim. Ligation of chimeric CD8
 
 
 
–
BAFF-R and, in particular, CD8
 
 
 
-TACI resulted in both
decreases in electrophoretic mobility and reduced Bim ex-
pression (Fig. 6 D). As a positive control, processing of NF-
 
 
 
B2 from its p100 precursor into the active p52 subunit was
also monitored. Ligation of chimeric BAFF-R, but not
TACI or BCMA, induced strong NF-
 
 
 
B2 p100 processing
(Fig. 6 D), which was consistent with a previous study (13).
Ligation of chimeric TACI also moderately increased p52
levels, but in the apparent absence of p100 processing.
 
Bim KO mice have elevated numbers of splenic T2 
and follicular (FO) mature B cells but reduced 
marginal zone (MZ) B cells
 
Bim KO mice have increases in splenic B cell numbers (19);
however, it is unclear whether this represents a global dysreg-
ulation of all splenic B cell populations or defects in specific B
cell subsets. To address this issue, we analyzed the numbers of
splenic T1, T2, FO, and MZ B cell populations in Bim KO
mice. The numbers of total splenic B cells were elevated
two- to threefold in Bim
 
 
 
/
 
 
 
 compared with WT mice (un-
published data) (19). These differences were reflected in the
2.5- and 4-fold increases in FO and T2–FO precursor (FOP)
splenic B cell numbers and a 1.5-fold increase in T2–MZ
precursor (MZP) B cells, respectively (Fig. 7, A and B). Re-
markably, Bim KO mice had similar numbers of T1 B cells
and twofold fewer MZ B cells in the spleen compared with
WT mice (Fig. 7 A), suggesting that regulation of Bim by
BAFF or other TNF family ligands is particularly important at
the T2 and FO B cell stages, whereas other BH3-only Bcl-2
family members may control homeostasis of T1 and MZ B
cell populations. We next tested whether Bim was required
for spontaneous- and BCR-induced cell death in different
splenic B cell subsets using B cells sorted based on their ex-
pression of CD21, CD23, and CD24. Spontaneous apoptosis
of immature T2, mature FO, and MZ B cells was strongly re-
duced in Bim KO mice compared with their WT counter-
Figure 6. Blockade of BCR-induced apoptosis by chimeric BAFF 
receptors correlates with changes in Bim mobility and expression. 
(A) Chimeric BAFF receptors were generated by in-frame fusion of the 
extracellular and transmembrane domains of mouse CD8  to the cyto-
plasmic regions of BAFF-R, TACI, and BCMA. (B) Surface levels of chimeric 
BAFF receptors on clonal WEHI-231 cell lines were quantified by FACS 
using biotinylated anti-CD8  mAb. Isotype control (open trace) and CD8  
cell surface (shaded trace) expression levels are shown. (C and D) Clonal 
WEHI-231 cell lines expressing chimeric BAFF receptors were incubated 
for 48 h with the indicated stimuli. Cell death was quantified by trypan 
blue staining. Results shown are the means   SD from at least three inde-
pendent clonal lines. Bim and NF- B2 were detected by immunoblotting 
of cell lysates as described in Fig. 3. A dividing line separates images from 
different parts of the same gel. n.s., nonspecific. 
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parts (Fig. 7 C), whereas spontaneous cell death of T1 B cells
was only moderately reduced after 24–48 h. BCR-induced
apoptosis was also strongly blocked in T2 and FO splenic B
cell populations from Bim KO compared with WT mice,
whereas BCR-induced cell death was observed in T1 B cells
from Bim KO mice, albeit at reduced levels compared with
WT mice (Fig. 7 D).
 
Expression of Bim and other BH3-only Bcl-2 family 
members in mouse splenic B lymphocyte subsets
 
The results in Fig. 7 suggest that different subpopulations of
splenic B cells may express distinct profiles of Bim and other
BH3-only Bcl-2 members. In addition, a recent study shows
that Bim is expressed at increasing levels during B cell devel-
opment in the bone marrow (44). Thus, T1, T2, FO, and
Figure 7. Splenic B cell subsets are dysregulated in Bim KO mice 
and differ in their expression of BH3-only Bcl-2 family members. 
(A) Splenic B cells were isolated from WT and Bim /  mice, stained with 
 IgD–FITC,  CD21–PE, and  IgM-PerCP, and the numbers of T1, T2-FOP, 
FO, T2-MZP, and MZ B cells were determined. Data shown are the means   
SEM from three mice per phenotype. MZ B cell numbers in WT and
Bim KO mice were 1.7   0.2   106 and 0.73   0.09   106, respectively. 
P   0.05 (*) and P   0.02 (**) were determined using an unpaired t test. 
(B) Cell lysates of isolated splenic B cells from WT and Bim /  mice were 
probed with anti-Bim or anti-actin (loading control). (C) T1, T2, FO, and 
MZ splenic B cell subsets were purified by FACS cell sorting using 
 CD21–FITC,  CD23-APC, and  CD24–PE. Spontaneous cell death 
was quantified at the indicated times by FACS using Mitotracker Red 
CMXRos. (D) T1, T2, and FO splenic B cell subsets were isolated as 
described in C and treated for 18 h with the indicated doses of anti-IgM, 
and cell death was analyzed as described in C. (E) T1, T2, FO, and MZ 
splenic B cell subsets were purified as described in C. Bim, Bik, Bmf, 
Noxa, Puma, and  -actin (loading control) were amplified by RT-PCR 
(Table S1), and PCR products were resolved as in Fig. 1D. (F) Splenic B cell 
subsets were isolated by FACS cell sorting as described above. Immuno-
blots were probed with anti-Bim or anti-actin (loading control).JEM VOL. 202, November 21, 2005 1371
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MZ B cells were isolated by cell sorting, and the levels of
BH3-only Bcl-2 family members were analyzed by RT-
PCR. Bim mRNA was detected in T1 but not T2 B cells
and was expressed at highest levels in FO B cells (Fig. 7 E).
Strikingly, Bik mRNA was selectively expressed in T1 B
cells but not detected in T2, FO, or MZ B cells (Fig. 7 E).
Two other BH3-only Bcl-2 family members, Bmf and
Noxa, were more ubiquitously expressed, with the highest
mRNA levels observed in T2 B cells. In contrast, Puma
mRNA appeared to be relatively restricted to MZ B cells
(Fig. 7 E). As mRNA expression of Bcl-2 family members
may not correlate with protein expression (45), we also ex-
amined Bim protein levels in splenic B cell subsets (Fig. 7 F).
Bim protein was expressed in each splenic B cell subset, with
T2 B cells expressing the lowest levels of Bim (Fig. 7 F).
DISCUSSION
Our results suggest that BAFF-mediated down-regulation of
Bim is a key mechanism by which BAFF promotes B cell
survival. The finding that BAFF affects B cell fate via its reg-
ulation of Bim is consistent with the striking similarity ob-
served between BAFF-transgenic and Bim KO mice. Both
have dysregulated B cell maturation leading to elevated
numbers of mature B cells and autoantibody-secreting
plasma cells (Fig. 7 A) (19, 31). Autoantigen-binding B cells
appear to have increased dependence on BAFF for their sur-
vival compared with naive B lymphocytes (22). Thus, in a
host with a diverse B cell repertoire with limiting quantities
of BAFF, autoantigen-binding B cells, which receive too lit-
tle BAFF to be protected from BCR-induced apoptosis, are
competitively eliminated. Importantly, the levels of Bim
protein were higher in autoantigen-binding B cells com-
pared with naive B cells, suggesting that BAFF acts, at least
in part, by blocking the function of Bim (22). Our finding
that BAFF down-regulates expression of Bim protein and
also promotes its phosphorylation thus provides clear evi-
dence that BAFF directly regulates Bim and antagonizes its
function (Figs. 3 and 5), underscoring that Bim is an impor-
tant target of BAFF-induced B cell survival.
BAFF appears to inhibit BCR-induced cell death by
promoting down-regulation of the proapoptotic BH3-only
family protein Bim rather than up-regulating antiapoptotic
Bcl-2 family members (Figs. 3 and 5). Indeed, BAFF did not
reproducibly change the levels of three key prosurvival Bcl-2
subfamily proteins, Bcl-xL, Bcl-2, or Mcl-1 (Figs. 3 and 5
and not depicted). A similar lack of effect of BAFF on Bcl-2,
Bcl-xL, Mcl-1, or A1 at the mRNA and protein level has
also been observed in purified B cells (22, 46, 47). In con-
trast, ligation of CD40, another antiapoptotic TNF receptor,
both down-regulated Bim and up-regulated Bcl-xL (Fig. 3
D). It is possible that BAFF’s inability to up-regulate Bcl-xL
reflects its preferential activation of the type 2 (p52-depen-
dent) as opposed to the type 1 (p50-dependent) NF- B
pathway (47). However, another report showed that BAFF
up-regulates Bcl-xL mRNA and protein via a p50 (NF-
 B1)-dependent pathway in mature mouse B cells (14). Al-
though an explanation for these differences remains unclear,
the coordinate activation of both type 1 and 2 NF- B path-
ways plays an important role in BAFF-mediated B cell sur-
vival (12–14).
Bim is a critical regulator of hematopoietic cell homeo-
stasis including both B and T lymphocytes (19–21, 44, 48).
In particular, studies using immunoglobulin- and TCR-
transgenic mice or self-antigen mouse models indicate Bim is
required for the deletion of autoreactive B and T cells (20,
21, 48). Thus, our results showing that siRNA-mediated
knockdown of Bim strongly reduces BCR-induced apopto-
sis are consistent with these studies and another report using
a human B cell line (49).
Intriguingly, analysis of the splenic B cell subsets in Bim
KO mice revealed increases in specific subsets as opposed to
a general increase in all B cell populations (Fig. 7 A). The
numbers of T2-FOP and FO B cells were increased 4- and
2.5-fold, respectively, suggesting that Bim is a key negative
regulator of homeostasis in these B cell subsets. In contrast,
Bim KO and WT mice had similar numbers of T1 B cells
(Fig. 7 A), suggesting that either Bim is not critical for the
homeostasis of T1 B cells, even though Bim protein is ex-
pressed in T1 B cells (Fig. 7 F), or that other BH3-only pro-
teins function in concert with Bim to control homeostasis.
Consistent with these ideas, T1 B cells from Bim KO mice
remained sensitive to both spontaneous- and BCR-induced
cell death, albeit at reduced levels compared with WT mice
(Fig. 7, C and D). A good candidate is Bik, which may reg-
ulate BCR-induced cell death (50). Not only do T1 B cells
express Bik mRNA (Fig. 7 E), but T1 B cells from BAFF-R
mutant mice express more Bik compared with WT mice
(51). Although no obvious defects in total splenic B cell
numbers were apparent in Bik KO mice (52), a detailed
analysis of transitional and MZ B cells was not performed.
The fact that T2 and FO B cells are elevated in Bim /  mice
suggests that BAFF-mediated control of Bim may be partic-
ularly important for the homeostatic control of these B cell
populations. Our result that Bim is expressed at higher levels
in T1 compared with T2 B cells suggests that BAFF may
function at the T2 stage to down-regulate Bim (Fig. 7 F),
which is consistent with studies showing that BAFF induces
survival of T2 B cells (7–9). Surprisingly, splenic MZ B cell
numbers were reduced in Bim /  mice (Fig. 7 A). Similar
decreases in MZ B cell numbers were also observed in E –
Bcl-2 transgenic mice (53). These mice also had enhanced
BCR-induced calcium responses consistent with a model in
which strong BCR signals favor FO versus MZ B cell devel-
opment (54). Thus, the absence of Bim may lead to more
free Bcl-2, such as in Bcl-2 transgenic mice, providing an
explanation for the reduced MZ B cell numbers. Collec-
tively, our results suggest that in addition to its role in pro-
moting cell death, Bim may also regulate B cell lineage deci-
sions, a possibility we are now investigating.
BAFF-induced blockade of BCR-induced cell death and
down-regulation of Bim correlated with sustained activation
of the MEK–ERK signaling pathway (Figs. 3, 5). Ligation ofBAFF CONTROLS B CELL SURVIVAL BY DOWNREGULATING BIM | Craxton et al. 1372
CD40 also induced a similar sustained pattern of ERK acti-
vation in WEHI-231 B cells (55). Indeed, pharmacological
blockade of BAFF-mediated ERK activation using the MEK
inhibitor U0126, strongly elevated BimEL protein levels
(Fig. 5 B), suggesting that the MEK–ERK pathway is re-
quired for BAFF-induced BimEL down-regulation. Previ-
ous studies have also shown that activation of the ERK path-
way in response to serum survival factors, PMA, IL-3, and
M-CSF, induces Bim phosphorylation, ubiquitination, and
degradation via the 26S proteasome (26, 27, 29, 30). In addi-
tion, phosphorylation of Bim may reduce its ability to di-
rectly interact with the proapoptotic multidomain Bcl-2
family protein Bax, thereby preventing oligomerization of
Bax and subsequent cell death (29). We observed that BAFF
blocked BCR-induced interactions between Bim and Bcl-2
(Fig. 3, E and F). In future studies, it will be important to
address whether BAFF-induced phosphorylation of Bim
perturbs its interaction with prosurvival Bcl-2 family mem-
bers such as Bcl-2, Bcl-xL, and Mcl-1. The apoptotic activity
of another BH3-only protein, Bad, is regulated by a similar
mechanism, in which Akt-mediated phosphorylation of Bad
promotes its association with 14–3-3 scaffold proteins and
sequesters Bad from Bcl-xL (56, 57).
BAFF promoted delayed but sustained activation of the
MEK–ERK pathway as assessed by increased phosphoryla-
tion of c-Raf, MEK, and ERK (Fig. 5, C and D). In con-
trast, BCR signaling induced rapid but transient ERK acti-
vation. Earlier experiments have shown that differences in
the duration or kinetics of ERK activation may “encode”
distinct biological outcomes such as cell proliferation and
differentiation (58). The dual specificity MAPK phosphatase
MKP-2/DUSP4 was strongly up-regulated in response to
BCR but not BAFF signaling (Fig. 5 C). Importantly, sus-
tained BCR signaling promotes MKP-2/DUSP4 up-regula-
tion and subsequent inhibition of ERK activation, which
correlates with accumulation of Bim (Fig. 5). In the future, it
will be important to test whether MKP-2/DUSP4 is in-
duced by activation of the MEK–ERK pathway and thereby
functions as part of a negative feedback loop to down-regu-
late BCR-induced ERK activation and promote cell death.
This possibility is supported by the observation that tran-
scriptional induction of another MKP family member, PAC-
1/DUSP2, which is also transcriptionally up-regulated by
BCR ligation, requires MAPK activation (59).
MATERIALS AND METHODS
Reagents. Human BAFF and a biotinylated derivative were gifts from J.
Gross (Zymogenetics, Seattle, WA). Human APRIL, mouse BAFF, and rab-
bit anti-Bmf serum were purchased from Axxora. Rabbit anti-Bim serum
was obtained from StressGen Biotechnologies. Rabbit antisera specific for
cleaved caspase-3, caspase-9, PARP, Bcl-xL, phospho-ERK, and phospho-
MEK were purchased from Cell Signaling Technology. Rabbit antisera spe-
cific for p38 MAPK, NF- B2, MKP-2, and goat anti-actin serum were ob-
tained from Santa Cruz Biotechnology, Inc. Rat anti-Bim (14A8) mAb was
purchased from Kamiya Biomedical. Goat anti–mouse IgM F(ab )2 fragments
were purchased from Jackson ImmunoResearch Laboratories. Biotin-conju-
gated anti-CD8 , FITC-labeled anti-IgD, PerCP-conjugated anti-IgM,
FITC- and PE-conjugated rat anti-CD21, and PE-conjugated rat anti-CD24
mAbs, a BD IMagnet, and a hamster anti-Bim (3F11) mAb were obtained
from BD Biosciences. APC-conjugated rat anti-CD23 was purchased from
Caltag. G418 sulfate, puromycin, U0126, and SB203580 were from EMD
Biosciences.    protein phosphatase and mouse anti–phospho–c-Raf (Ser
338) serum were obtained from Upstate Biotechnology.
B cells and cell lines. Mouse WEHI-231 and A20 and human Daudi B
cell lines were obtained from American Type Culture Collection and cul-
tured as described previously (60). Mouse splenic B cells were isolated using
a BD-IMagnet, and T1, T2, FO, and MZ B cells were sorted using mAbs
to CD21, CD23, and CD24 as previously described (6, 34). mAbs to IgM,
IgD, and CD21 were used to analyze splenic B cells as T1, T2-FOP, T2-
MZP, FO, and MZ based on relative expression of CD21 (61). For cell
stimulations, WEHI-231 B cells were treated with 10  g/ml anti-IgM in
the presence or absence of 100 ng/ml BAFF or 100 ng/ml APRIL unless
otherwise described in the figure legends.
Mice. Bim /  (B6.129-Bcl2l11tm1.1Ast/J) and C57BL/6J mice were obtained
from the Jackson Laboratory. Mice were housed under specific pathogen-free
conditions, and all experiments were performed in compliance with the Uni-
versity of Washington Institutional Animal Care and Use Committee.
CD8 –BAFF receptor retroviral constructs and retroviral trans-
duction of WEHI-231 cells. Extracellular and transmembrane regions of
mouse CD8  were amplified using Pfu Turbo DNA polymerase from
pcDNA3-CD8 -Ig CT and ligated into the XhoI and BamHI sites of
pLXSN (CLONTECH Laboratories, Inc.). Pfu Turbo–amplified cytoplasmic
portions of each BAFF receptor were then inserted into the BamHI site of
pLXSN-mCD8 . Constructs were verified by automated DNA sequencing.
Vectors were transiently transfected into the ecotropic packaging line PE501
by calcium phosphate precipitation. PE501 viral supernatants were used to
transduce the amphotropic packaging line PA317 and stable cell lines ob-
tained by selection in 0.8 mg/ml G418. Retroviral supernatants were used to
transduce WEHI-231 cells and stable polyclonal cell lines obtained by selec-
tion in 1 mg/ml G418. Clonal WEHI-231–CD8 –BAFF receptor–express-
ing cell lines were obtained by limiting dilution in the presence of G418.
Stable Bim siRNA-expressing WEHI-231 B cell lines. Bim siRNAs
were designed to regions of mouse Bim common to all major isoforms (nt
13–31 and 488–506) as described previously (29). Oligonucleotides were
synthesized according to the manufacturer’s guidelines (Oligoengine), an-
nealed to create BglII and HindIII sites, phosphorylated, and ligated into
shrimp alkaline phosphatase–treated vector to generate pSuperRetroPuro-
Bim-siRNA. Inserts were verified by automated DNA sequencing.
HEK293T cells were cotransfected with pSuperRetroPuro-control or
-BimsiRNA vectors, pVPack-GP, and pVPack-10A1 by calcium phosphate
precipitation. Viral supernatants were used to transduce WEHI-231 B cells
in the presence of 10  g/ml polybrene and polyclonal cell lines obtained by
selection in 1  g/ml puromycin.
RT-PCR. RT-PCR was performed as previously described (62).
Western blotting and immunoprecipitation. Cell lysates were pre-
pared by brief sonication on ice, and immunoblotting was performed as
described previously (60). Immunoprecipitations were performed using
NP-40 lysis buffer (10 mM Na2HPO4, 150 mM NaCl, 2 mM EDTA, 1%
NP-40, pH 7.2) containing 1 mM Na3VO4, 50 mM NaF, 1  g/ml leupep-
tin, 1  g/ml aprotonin, 1  g/ml pepstatin, and 1 mM PMSF and immune
complexes captured using protein G–sepharose beads. Bands from immuno-
blots were quantified by scanning densitometry software (Image version
1.63; National Institutes of Health).
  protein phosphatase treatment. Cell lysates were prepared using Ige-
pal Lysis Buffer without inhibitors (10 mM triethanolamine, 150 mMJEM VOL. 202, November 21, 2005 1373
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NaCl, 1 mM EDTA, 1% Igepal, pH 7.8). After a 10-fold dilution in  
phosphatase buffer, lysates were incubated with 150 U   protein phos-
phatase for 15 min at 37 C before SDS-PAGE.
Cell death assays. Apoptotic cells were detected by TdT-mediated
dUTP nick-end labeling with an In Situ Cell Death Detection Kit (Boeh-
ringer Mannheim) as previously described (63).   m was measured by
FACS using 50 nM Mitotracker Red CMXRos (Invitrogen). Data were
analyzed using Cellquest software.
Online supplemental material. Table S1 shows the sequences of prim-
ers used for RT-PCR analysis of BAFF receptors and BH3-only Bcl-2 fam-
ily members. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20051283/DC1.
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